Thomas E. Hughes

Also affiliated with National Cancer Institute, Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia”.

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003392

N/A

2.1DataRank · unranked

77 citations

Gege Gui, Laura W. Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez +17 more

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation

Blood Advances(2025)10.1182/bloodadvances.2024014879

N/A

0.783DataRank · unranked

24 citations

Dimana Dimitrova, Ruby Sabina, Ashley DeVries, Jeannine S. McCune, Meredith J. McAdams +17 more

High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention

Blood Advances(2024)10.1182/bloodadvances.2023010973

N/A

0.451DataRank · unranked

11 citations

Lauren M. Curtis, Rachel B. Salit, Brian C. Shaffer, Filip Pirsl, Alen Ostojić +14 more

Hematopoietic cell transplantation for DOCK8 deficiency: Results from a prospective clinical trial

Journal of Allergy and Clinical Immunology(2024)10.1016/j.jaci.2024.08.021

N/A

0.345DataRank · unranked

9 citations

Corina Gonzalez, Bonnie Yates, Kristen Cole, Lauren Little, Erin Flannelly +18 more

Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia

medRxiv(2021)10.1101/2021.06.23.21258377

N/A

0.292DataRank · unranked

6 citations

Gege Gui, Laura W. Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez +17 more

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1888379

N/A

0.286DataRank · unranked

4 citations

Clifton C. Mo, Erika M. Gaglione, Constance M. Yuan, Maryalice Stetler‐Stevenson, Xin Tian +20 more

Further Personalizing Medicine in Immune Disorders: Genomic Findings and Hematopoietic Cell Transplantation Survival

Transplantation(2025)10.1097/tp.0000000000005504

N/A

0.104DataRank · unranked

1 citations

Sarah A. Bannon, Jia Yan, Rajarshi Ghosh, Ekaterina Damskey, Breanna Beers +41 more

Phase I results of human endogenous retrovirus type-E (HERV-E) TCR transduced T-cells in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2549

N/A

0DataRank · unranked

5 citations

Stefan Barisic, Gina Scurti, Elena Cherkasova, Long Chen, Kristen Wood +13 more

A prospective evaluation on the interaction of fluconazole and voriconazole on serum concentrations of budesonide in patients treated for gastrointestinal GVHD

Bone Marrow Transplantation(2020)10.1038/s41409-020-0786-8

N/A

0DataRank · unranked

4 citations

Lindsay Stansfield, Parag Kumar, Tatyana Worthy, Xin Tian, Richard Childs +1 more

Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor

Haematologica(2020)10.3324/haematol.2019.236182

N/A

0DataRank · unranked

60 citations

Alexis Leonard, David F. Stroncek, Sandhya R. Panch, Kamille A. West, Eoghan Molloy +12 more